Cited by 998Aluminum toxicity and tolerance in plants and animalsHeavy Metal Exposure and ToxicityCarcinogens and Genotoxicity Assessment

Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide

Open access
Krewski, Daniel, Yokel, Robert A, Nieboer, Evert, Borchelt, David, Cohen, Joshua, Harry, Jean, Kacew, Sam, Lindsay, Joan +2 more·2007·Journal of Toxicology and Environmental Health, Part B

Abstract

Note: This article was originally published with an incorrect version of the Acknowledgments, which appeared on p. 218 of the print version. The correct version of the Acknowledgments appeared on pp. 1–2. The corrected article is available below.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/10937400701597766

Cites

1422 of 1422 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The total body burden of aluminium in healthy humans is approximately 30-50 mg/kg body weight and normal levels of aluminium in serum are approximately 1-3 μg/L.

    “The total body burden of Al in healthy humans has been reported to be approximately 30–50 mg/kg body weight and normal levels of Al in serum are approximately 1–3μg/L (Krewski et al., 2007).”

    From Aluminium toxicosis: a review of toxic actions and effects (2019) · cites this paper as Krewski et al., 2007

    The Kinetics and Metabolism passage (page not provided) says normal plasma aluminium is believed to be 1–2 μg/L and that steady-state serum and whole-blood concentrations are approximately equal. This broadly supports the serum figure, though not its exact 1–3 μg/L range. The passages found describe how aluminium is distributed in the body but do not support a total body burden of 30–50 mg/kg body weight. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Aluminium levels increase with age in tissues and organs (bone, muscle, lung, liver, and kidney) of experimental animals.

    “Al levels increase with age in tissues and organs (bone, muscle, lung, liver, and kidney) of experimental animals (Krewski et al., 2007).”

    From Aluminium toxicosis: a review of toxic actions and effects (2019) · cites this paper as Krewski et al., 2007

    The animal-studies passage in “Distribution (Including Compartmentalization)” (page not provided) reports age-related increases in each listed tissue in at least one experimental animal study. The claim omits important limits: rat muscle aluminium decreased at 24 months, while mouse femur and lung aluminium decreased with age. The pattern is therefore not a general increase across those tissues in experimental animals. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The aluminium ion in blood circulation is eliminated primarily by the kidneys (about 95%) in the urine, presumably as aluminium citrate.

    “The Al ion in blood circulation is eliminated primarily by the kidneys (about 95%) in the urine, presumably as Al citrate (Shirley and Lote, 2005; Krewski et al., 2007; Anon, 2008c).”

    From Aluminium toxicosis: a review of toxic actions and effects (2019) · cites this paper as Krewski et al., 2007

    The Kinetics and Metabolism section (page unavailable) says that greater than 95% of aluminium is eliminated by the kidney, supporting the main route and approximate proportion. The copy also says aluminium citrate may enhance renal elimination, but it does not establish that aluminium is excreted in urine specifically as aluminium citrate. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Aluminium rapidly enters the brain, extracellular fluid and the cerebrospinal fluid, with smaller concentrations in these organs than in the blood.

    “Moreover, Al has been shown to rapidly enter the brain, extracellular fluid and the cerebrospinal fluid, with smaller concentrations in these organs than in the blood (Martin, 1992; Krewski et al., 2007).”

    From Aluminium toxicosis: a review of toxic actions and effects (2019) · cites this paper as Krewski et al., 2007

    The Distribution (Including Compartmentalization) section says aluminium can rapidly enter brain extracellular fluid and cerebrospinal fluid, and that concentrations in those two fluids are lower than in blood. It also describes aluminium entering the brain, but does not extend the rapid-entry and lower-than-blood comparison to the brain as a whole. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

4 of the 1426 references couldn’t be matched to a known paper.

Research works printed but not linked: 148

  1. AAMI (Association for the Advancement of Medical Instrumentation). Water Quality for Dialysis. Vol. 3. Arlington: AAMI WQD; 1998.
  2. ACGIH (American Conference of Governmental Industrial Hygienists). 1995-1996 Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 1996. ACGIH (American Conference of Governmental Industrial Hygienists). Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 2005.
  3. Alfrey AC. Aluminum metabolism in uremia. Neurotoxicology 1980;1:43-53.
  4. Alfrey AC, Hegg A, Miller N, Berl T, Berns A. Interrelationship between calcium and aluminum metabolism in dialyzed uremic patients. Miner Electrol Metab 1979;2:81-87.
  5. Anane R, Bonini M, Grafeille J, Creppy E. Skin absorption and hippocampal bioaccumulation of water soluble aluminum chloride in mice (abstract). Hum Exp Toxicol 1995;14:531.
  6. Barr M, Glenny AT, Butler NR. Immunization of babies with diphtheriatetanus-pertusis prophylactic. Br Med J 1955;2:635-639. [PubMed: 13240204]
  7. Bast-Pettersen R, Skaug V, Ellingsen D, Thomassen Y. Neurobehavioral performance in aluminum welders. Am J Ind Med 2000;37:184-192. [PubMed: 10615099]
  8. Benet, LZ.; Kroetz, DL.; Sheiner, LB. Pharmacokinetics. The dynamics of drug absorption, distribution, and elimination. In: Hardman, JG.; Limbird, LE.; Molinoff, PB.; Ruddon, RW.; Gilman, AG., editors. Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996. p. 3-28.
  9. Bernier RH, Frank JA, Nolan TF. Abcesses complicating DTP vacccination. Am J Dis Child 1981;135:826-828. [PubMed: 7282659]
  10. Blank IH, Jones JL, Gould E. A study of the penetration of aluminum salts into excised skin. Proc Sci Sect Toilet Goods Assoc 1958;29:32-35.
  11. Bougle D, Bureau F, Morello R, Guillow B, Sabatier JP. Aluminum in the premature infant. Trace Elem Electrolytes 1997;14:24-26.
  12. Budavari, S.; O'Neil, MJ.; Smith, A.; Heckelman, PE. The Merck Index. Vol. 11. Rathway, N.J.: Merck & Co. Inc; 1989.
  13. Channon SM, Arfeen S, Ward MK. Long-term accumulation of aluminium in patients with renal failure. Trace Elem Med 1988;5:154-157.
  14. Chernov VK, Lazareva V, Asmolov AI, Markova SB. Content of some trace elements in plasma and erythrocytes. Zdravookhranenie Kazakhstana 1977;4:80-81.
  15. Clonfero E, Caroldi S, Cortese M, Zambon P. Health problems in aluminum foundry workers of Porto Marghera [Italy]. Part II. Chronic bronchitis. Securitas 1980a;64:60-62.
  16. Clonfero E, Caroldi S, Cortese M, Zambon P. Health problems in aluminum foundry workers of Porto Marghera [Italy]. Part III. Alumina-induced pneumoconiosis. Securitas 1980b;64:63-66.
  17. Washington D.C.: National Academy Press; 1984.
  18. Daniela B, Antonella D, Antonela L. Aluminum contamination in home parenteral nutrition patients. J Parenter Enteral Nutr 2002;26:S30-S31.
  19. De Marchi J. Uber experimentelle aluminium-staubungen. Grenzgeb Einzeldarst 1947;4:28.
  20. De Vuyst P, Dumortier P, Schandené L, Estenne M, Verhest A, Yernault JC. Sarcoid-like lung granulomatosis induced by aluminum dust. Am Rev Respir Dis 1987;135:493-497. [PubMed: 3813209]
  21. Del'va VA. Changes in the concentration of aluminum of the blood and cerebrospinal fluid in some pathologic processes. Ref Zh Khim Biol Khim 1962;19:193-195.
  22. Delves HT, Sieniawaska CE, Suchak B. Total and bioavailable aluminium in foods and beverages. Anal Proc (London) 1993;30:358-360.
  23. Denny JJ, Robson WD, Irwin DA. The prevention of silicosis by metallic aluminum. Can Med Assoc J 1937;37:1-11.
  24. Doese M. Industrial medicine studies on injury to health caused by aluminium, in particular lung disease from aluminium dust. Arch Gewerbepathol 1938;8:501-531.
  25. Hetland, S.; Schmidt, F.; Thomassen, Y. Uptake and Excretion of Aluminum in Workers Exposed to Aluminum Fluoride and Aluminum Oxide. Aluminum Association. Aluminum and Health, 2nd International Conference; Tampa, Florida. 1992. p. 157-160.
  26. Driscoll, CT.; Schecher, WD. Aqueous chemistry of aluminum. In: Gitelman, HJ., editor. Aluminum and Health a Critical Review. New York: Marcel Dekker; 1989. p. 27-65.
  27. DuVal G, Brubb B, Bentley P. Aluminum accumulation in the crystalline lens of humans and domestic animals. Trace Elem Med 1986;3:100-104.
  28. Edling NPG. Aluminum pneumoconiosis: A roentgendiagnostic study of five cases. Acta Radiol 1961;56:170-178. [PubMed: 13889219]
  29. Eickhoff TC, Myers M. Aluminum in vaccines. Vaccine 2002;20:S1-S4. [PubMed: 12184358]
  30. Elorriaga R, Fernández Martin JL, Menéndez Fraga PM, Naves ML, Braga S, Cannata JB. Aluminium removal: short and long-term preliminary results with L1 in rats. Drugs Today 1992;28:177-182.
  31. EPA (Environmental Protection Agency). National ambient air quality standards for particulate matter; final rule. Fed Reg 1997;62:38651.
  32. ESIS (European Chemical Substances Information System). 2007. [online]. Cited 24 January 2007. http://ecb.jrc.it/esis Esmonde TF. Cerebral dysfunction after a water pollution incident in Camelford: Study has several methodological errors. Br Med J 2000;320:1337-1338. [PubMed: 10885915]
  33. Fernández F, Bernaola G, Muñoz DG, Fernandez de Corres L. Nodulos subcutáneous por sensibilización a aluminio en pacientes tratados mediante inmunoterapia con extratos semidepot. Dermititis Contacto 1990;16:57-60.
  34. Forbes WF, Hayward LM, Agwani N. Dementia, aluminum, and fluoride. Lancet 1991;338:1592-1593. [PubMed: 1683989]
  35. Frash VN, Vanchugova NN, Rukoleeva SN, Zykova VA, Grebennikov SA, Shcherbakov SV. Carcinogenic effects of some nonfibrous mineral dusts. Byull Eksp Biol Med 1992;114:648-651.
  36. Frostad AW. Fluorine intoxication in Norwegian aluminium plant workers. Tidskr Nor Laegenforen 1936;56:179-182.
  37. Furst A. Trace elements related to specific chronic diseases. Cancer Geol Soc Am Mem 1971;123:109- 114.
  38. Furst A, Haro RT. A survey of metal carcinogenesis. Prog Exp Tumor Res 1969;12:102-133. [PubMed: 4905208]
  39. Gardner LU, Dworski M, Delahant AB. Aluminum therapy in silicosis: An experimental study. J Ind Hyg Toxicol 1944;26:211-223.
  40. Gardner MJ, Gunn AM. Speciation and bioavailability of aluminum in drinking waer. Chem Speciat Bioavail 1995;7:9-16.
  41. Gherardi RK, Cherin P. Macropagic fascitis: a new entity. Groupe d'etudes et recherche surles maladies musculaires acquises et disimmunitaires (GERMMAD) de l'association francaise contre les myopathies (AFM). Rev Med Interne 1998;19:617-618. [PubMed: 9793147]
  42. Glenny AT, Popk CG, Waddington H, Wallace U. Immunological notes. XXIII. The antigenic value of toxoid precipitated by potassium alum. J Pathol Bacteriol 1926;29:38-39.
  43. Golub MS, Han B, Keen CL. Al and Mn: Interactions in adult and developing mice. Teratology 1991;43:490.
  44. Goralewski G. Klinische und tierexperimentelle studien sur frage der aluminum-staublunge. [Clinical and animal experimental studies and the question of the aluminum-dusty lung]. Arch Gewerbepathol Gewerbehyg 1939;9:676-688.
  45. Goralewski G. Zur symptomalogie der aluminum-staublunge. [The symptomatology of the aluminum dust lung]. Arch Gewerbepathol Gewerbehyg 1940;10:384-408.
  46. Goralewski G. Zur klinik der aluminumlunge [Clinical examination of the aluminum lung]. Arch Gewerbepathol Gewerbehyg 1941;11:108-116.
  47. Goralewski G. Weitere erfahrungen zum krankheitsbild der aluminumlunge. Dtsch Tuberk Bl 1943;17:2- 10.
  48. Goralewski G. Die aluminiumlunge-eine neue gewerbeerkrankung. [The aluminum lung: a new industrial disease]. Z Gesamte Inn Med 1947;2:665-673.
  49. Goralewski G. The aluminium lung: A new industrial disease. Br J Ind Med 1948;6:53-54.Abstract of Goralewski, 1947
  50. Greenberg S. The pulmonary effects of pure aluminum in the Swiss mouse. Lab Invest 1977;36:339.
  51. Hannon JW. Aluminum therapy in silicosis. Trans Canad Min 1944;47:180.
  52. Hannon, JW. Proceedings of the 5th Conference of McIntyre Research Foundation on silicosis; 1953.
  53. Hem SL. Elimination of aluminium adjuvants. Vaccine 2002;20(Suppl 3):S40-S43. [PubMed: 12184363]
  54. Hem, SL.; White, JL. Pharmaceutical uses of aluminum. In: Gitelman, HJ., editor. Aluminum and Health A Critical Review. New York: Marcel Dekker; 1989. p. 257-282.
  55. Hemmer W, Wantke F, Focke M, Gotz M, Jarisch R. Evaluation of cutaneous hypersenstivity to aluminum by routine path testing with AlCl. Contact Dermatitis 1996;34:217-218. [PubMed: 8833470]
  56. Hertzberg M, Zlochower IA, Cashdollar KL. Explosibility of metal dusts. Comb Sci Tech 1991;75:161- 165.
  57. Hohl C, Gerisch P, Korschinek G, Nolte E, Ittel TH. Medical application of 26 Al. Nucl Instr Meth Phys Res B 1994;92:478-482.
  58. IARC (International Agency for Research on Cancer). Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs (Volumes 1 to 42). Lyon, France: World Health Organization, International Agency for Research on Cancer; 1987. ICRP (International Commission of Radiological Protection). Limits on Intakes of Radionuclides by Workers. Oxford: Pergamon; 1975. Metabolic data for aluminium; p. 12-13. ICRP (International Commission of Radiological Protection). Limits for Intakes of Radionuclides by Workers. Oxford: Pergamon Press; 1981.
  59. Ittel TH, Gerisch P, Nolte E, Sieberth HG. Fractional absorption of aluminium is dose-dependent: A 26 Al tracer study. Nephrol Dial Transplant 1993b;8:993.
  60. Iwata S, Kasajima K, Yase Y, Yoshimasu F, Kamiayashi Y. Radioactivation analysis of amyotrophic lateral sclerosis. Kyoto Daigaku Genshiro Jikkensho Gakujutsu Koenkai Koen Yoshishu 1976;10:33-38.
  61. Jagannatha Rao K, Rao R, Shanmgaveu P, Menon R. Trace elements in the cerebrospinal fluid in Alzheier's disease. Alz Rep 1999;2:333-338.
  62. Jäger R, Jäger F. Colloid chemistry and histochemistry in the problem of pulmonary disease caused by aluminum dust. Archiv fuer Gewerbepathologie und Gewerbehygiene 1941;11:117-130.
  63. Johns DR, Petronella SJ. Aluminum therapy for silicosis. Monthly Bull Indiana State Board Health 1945;43:203.
  64. Jötten KW, Eickhoff W. Risk of lung damage by Al dust. I. Literature and discussion of hygienic technique. Archiv Fuer Hygiene und Backteriologie 1942;127:344-367.
  65. Jouhanneau P, Raisbeck GM, Yiou F, Lacour B, Banide H, Drüeke TB. Gastrointestinal absorption, tissue retention, and urinary excretion of dietary aluminum in rats determined by using 26 Al. Clin Chem 1997b;43:1023-1028. [PubMed: 9191556]
  66. Karlik SJ, Eichhorn GL, Crapper DR. Molecular interactions of aluminum with DNA. Neurotoxicology 1980a;1:83-88.
  67. King EJ, Rogers N, Gilchrist M. Attempts to prevent silicosis with aluminium. J Pathol Bacteriol 1945;57:281.
  68. Knutti R, Zimmerli B. Investigation of the daily portions of Swiss food establishments: III. Lead, cadmium, mercury, nickel and aluminium. Mitt Geb Lebensm Hyg 1985;76:206-232.
  69. Koelsch F. Pulmonary disease caused by aluminum dust. Beitr Klin Tuberk 1942;97:688-693.
  70. Krasnukhina AV, Laptev SF, Vakhramova SP. Reactions of some metal cations with oleic acid in water. Sb Tr Tsent Nauch Issled-Inst Olovyan Prom 1971;1:69-71.
  71. Kukhtina AP. Effect of age and the functional condition of the central nervous system on the level of some trace elements in the skeletal muscles and blood of white rats. Mikroelementy v Meditsine 1972;3:123-126.
  72. Kumar S. Aluminum-induced biphasic effect. Med Hypotheses 1999;52:557-559. [PubMed: 10459838
  73. Lakatos A, Banyai I, Decock P, Kiss T. Time-dependent solution speciation of the Al III -citrate system: potentiometric and NMR studies. Eur J Inorg Chem 2001;2001:461-469.
  74. Lesnikovich AI, Shunkevich TM, Vorob'eva JA, Maumenko VN. Interaction of highly dispersed aluminum with oleic acid. Vestnik Belorusskogo Gosudarstvennogo Universiteta, Seriya 2: Khimiya Biologiya Geografiya 1993;1:7-9.
  75. Letzel S, Schaller KH, Angerer J, Drexler H, Weber A, Schmid K, Weltle D. Biological monitoring of occupational aluminum powder exposure. Occup Hyg 1996;3:271-280.
  76. Lewis CW, Macias ES. Composition of size-fractioned aerosols in Charleston, WV. Atmos Environ 1980;14:185-194.
  77. Lewis, JL.; Hahn, FF.; Dahl, AR. Transport of inhaled toxicants to the central nervous system. Characteristics of a nose-brain barrier. In: Isaacson, RL.; Jensen, KF., editors. The Vulnerable Brain and Environmental Risks, Vol 3: Toxins in Air and Water. New York: Plenum Press; 1994. p. 77-103.
  78. Linse R, Hadlich J, Kirsten D. Cutaneous foreign body granulomas casued by aluminium hydroxide after desensitization with Mischpollen-Depotallergen. Dermatol Monatsschr 1979;165:653-657. [PubMed: 393554]
  79. Linss VW, Martin R, Stein G, Bräunlich H, Fleck C. Electron microscopic evidence of aluminium in lysosomes of kidney cells by electron energy loss spectroscopy. Acta Histochem 1991;90:65-73. [PubMed: 2048391]
  80. Linton RW, Bryan SR, Griffis DP, Shelburne JD, Fiori CE, Garruto RM. Digital imaging studies of aluminum and calcium in neurofibrillary tangle-bearing neurons using secondary ion mass spectrometry. Trace Elem Med 1987;4:99-104.
  81. MacFarland HN, Hornstein N. An experimental investigation of the effects of the inhalation of alumina and other fumes. Can Chem Process Industries 1949;33:145.
  82. Manna GK, Das RK. Chromosome aberration in mice induced by aluminum chloride. Nucleus 1972;15:180-186.
  83. Maynard, EA. Gold, silver, manganese, and other minor metals. In: DiPalma, JR., editor. Drill's Pharacology in Medicine. Vol. 3. New York: McGraw-Hill Book Company; 1965. p. 872-887.
  84. McGregor SJ, Fernandez Menendez MJ, Naves ML, Elloriaga R, Brock JH, Cannata JB. The uptake of aluminum and its effect on iron metabolism in the osteoblast like cell line MG-63. Trace Elem Electrolytes 1994;11:187-191.
  85. Meshitsuka S, Inoue M. Urinary excretion of aluminum from antacid ingestion and estimation of its apparent biological half-time. Trace Elem Electrolytes 1998;15:132-135.
  86. Meshitsuka S, Matsushima F, Nose T. Absorption of aluminum from aspirin preparations with aluminum glycinate. Trace Elem Electrolytes 1999;16:175-176.
  87. Meyer FA, Kasper W. Examination of the effects of aluminium on the lung. Dtsch Arch Klin Med 1942a; 189:471-495.
  88. Meyer FA, Kasper W. Results of examination of workers in an aluminum-stamping works. Sitzber physik -med Sozietat Erlangen 1942b;73:71-75.
  89. Migliore L, Cocchi L, Nesti C, Sabbioni E. Micronuclei assay and FISH analysis in human lymphocytes treated with six metal salts. Environ Mol Mutagen 1999;34:279-284. [PubMed: 10618176]
  90. Mizumoto Y, Iwata S, Sasajima K, Yoshimasu F, Yase Y. X-ray florescence analysis for trace elements in frontal cortex in amytrophic lateral sclerosis. Kinki Daigaku Genshiryoku Kenkyusho Nenpo 1983;20:1-4.
  91. Mödder H, Schmitt T. Spreading of aluminosis. Dtsch Med Wochenschr 1951;76:84-87. [PubMed: 14813007]
  92. Müller, M.; Anke, M.; Illing-Günther, H. Oral aluminium exposure of adults in Germany -A long-term survey. In: Fischer, P.; L'Abbé, M.; Cockell, K.; Gibson, R., editors. Trace Elements in Man and Animals -9: Proceedings of the Ninth International Symposium on Trace Elements in Man and Animals. Ottawa, Canada: NRC Research Press; 1997. p. 177-178.
  93. Neri LC, Hewitt D. Aluminum, Alzheimer's disease, and drinking water. Lancet 1991;338:390. [PubMed: 1677733]
  94. Nieboer E, Thomassen Y, Chashchin V, Odland JO. Occupational exposure assessment. J Environ Monit 2005;7:411-415.
  95. NRC (National Research Council). Airborne Particles. Baltimore: University Park Press; 1979.
  96. Washingon D.C.: National Academy Press; 1983.
  97. Ogugbuaja VO, Onyeyili PA, Gadam AA, William A. The bioaccumulation of aluminium from coal ash on the tissue of rabbits: an environmental toxicology study. J Chem Soc Nigeria 2004;29:1-4.
  98. Olaizola I, Fernández Martin JL, Fernández Menéndez MJ, Vizoso Piñeiro FJ, Virgós MJ, Fernández Soto I, Roza Suárez M, Cannata JB. Aluminium hydroxide absorption: Effect of age, renal failure and aluminium overload. Kidney Int 1989;36:147.
  99. Waldron-Edward, D., editors. Intestinal Absorption of Metal Ions, Trace Elements and Radionuclides. Oxford: Pergamon; 1971. p. 293-305.
  100. Pennington, JA.; Jones, J. Aluminum in american diets. In: Gitelman, HJ., editor. Aluminum in Health, A Critical Review. New York: Marcel Dekker; 1989. p. 67-100.
  101. Perez Parajon J, Gonzalez FB, Cannata JB, Sanz Medel A. A critical appraisal of the speciation of aluminum in serum b ultrafiltration. Trace Elem Med 1989;6:41-46.
  102. Peserico A. Pathogenesis of Porphyria cutanea tarda-like syndrome. Nephron 1979;24:51. [PubMed: 492408]
  103. O'Donnell, TV., editors. Health in the Aluminium Industry. London, UK: Middlesex University Press; 1998. p. 68-69.
  104. Quarles LD, Dennis VW, Gitelman HJ, Harrelson JM, Drezner MK. Aluminum deposition at the osteoid- bone interface. J Clin Invest 1985;75:1441-1447. [PubMed: 3998143]
  105. Quatrale RP. Mechanism of antiperspirant action. Cosmet Toiletries 1985;100:23-26.
  106. Rees EL. Aluminum toxicity as indicated by hair analysis. J Orthomol Psych 1979;8:37-43.
  107. Renard JL, Felten D, Bequet D. Post-otoneurosurgery aluminum encephalopathy. Lancet 1994;344:63- 64. [PubMed: 7912334]
  108. Rifat, SL. Cognitive deficit after exposure to McIntyre powder: exposure effect or artifact?. Second international conference on aluminum and health; Tampa, Florida. 1992.
  109. Rodushkin I, Odman F. Application of ICP-MS for elemental analysis of urine. J Trace Elem Med Biol 2001;14:241-247. [PubMed: 11396785]
  110. Roider G, Drasch G. Concentration of aluminum in human tissues-investigations on an ocupationally non-exposed population in Southern Bavaria (Germany). Trace Elem Electrolytes 1999;16:77-86.
  111. Rollin HB, Theodorou P, Nogueir CM, Levin J. Aluminium uptake and excretion in potroom workers of a new primary aluminium smelter during the construction stage. J Environ Monit 2001;3:560-564. [PubMed: 11785626]
  112. San LN, Uysal H, Gokbel H, Bediz LS, Sayal A. Pulmonary function of workers in the aluminum industry. Am J Ind Med 1997;33:305-307. [PubMed: 9481430]
  113. Santaroni P. Ingestion of aluminum in the diet and evaluation of safety levels in Italy. Rivista di Tossicologia: Sperimentale e Clinica 1990;20:25-30.
  114. Savory J, Brown S, Bertholf RL, Mendoza N, Wills MR. Aluminum. Methods Enzymol 1988;158:289- 301. [PubMed: 3374379]
  115. Sax, NI.; Lewis, RJ., Sr, editors. Hawley's Condensed Chemical Dictionary. Vol. 11. New York, NY: Van Nostrand Reinhold; 1987. p. 1248-1249.
  116. Schlatter, C.; Steinegger, A. Limitations of biological monitoring of aluminium exposure. Second international conference on aluminum and health; Tampa, Florida. 1992.
  117. Schönholzer K, Sutton R, Walker V, Sossi V, Schulzer M, Venczel E, Johnson R, Vetterli D, Dittrich B, Suter M. Is intestinal aluminum absorption enhanced in the renal failure rat? J Am Soc Nephrol 1992;3:676.abstract
  118. Schulz W, Deuber HJ, Popperl G. On the differential diagnosis and therapy of dialysis osteomalacia under special consideration to a therapy with oral phosphate binders. Trace Elem Med 1984;1:120-127.
  119. Seko Y, Nakamura I, Sugamata M, Nonaka K, Miura T. A possible increase in the concentration of aluminum in the brain of rats infected with Japanese encephalitis virus; an investigation by neutron activation analysis. Igaku to Seibutsugaku 1986;113:367-370.
  120. Selden AI, Westberg HB, Axelson O. Cancer morbidity in workers at aluminum foundries and secondary aluminum smelters. Am J Ind Med 1997;32:467-477. [PubMed: 9327070]
  121. Seo KS, Lee CS. Mutagenicity of metal compounds using Escherichia coli WP2 UVRA. Misaengmul Hakhoechi 1993;31:527-531.
  122. Shaver CG. Pulmonary changes encountered in employees engaged in the manufacture of alumina abrasives. Occup Med 1948;5:718-728. [PubMed: 18113773]
  123. Shore D, Wyatt RJ. Aluminum and Alzheimer's disease. J Nerv Ment Dis 1983;171:553-558. [PubMed: 6350535
  124. Simonyte S, Cherkashin G, Sadauskiene I, Planciuniene R, Stapulionis R, Ivanov L. Effects of lead and aluminum on the specific immune response of growing mice. Ekologija 2004;2:16-20.
  125. Sjögren B. Occupational aluminum exposure. Neurotoxicology 2000;21:871.
  126. Sjögren, B.; Elinder, CG.; Iregren, A.; McLachlan, DRC.; Riihimaki, V. Occupational aluminum exposure and its health effects. In: Yokel, RA.; Golub, MS., editors. Aluminum Toxicity. Washington DC.: Taylor & Francis; 1997. p. 165-183.
  127. Elingsen, DG.; Jordbekken, L.; Notø, H.; Thomassen, Y. Measurement strategies for peak exposure to gases and aerosols. Abstract 0-60, Fifth International Symposium on Modern Principles of Air Monitoring (Including Biomonitoring), Airmon 2005;
  128. Sleppy, WC. Aluminum compounds. In: Kroschwitz, JI.; Howe-Grant, M., editors. Kirk-Othmer Encylopedia of Chemical Technology. Vol. 2. New York: John Wiley & Sons; 1992. p. 252-267.
  129. Smith, Q.; Mori, H.; Swyt, C.; Atack, J.; Rapoport, S. Electron probe microanalysis of aluminum and silicon in Alzheimer's disease senile palques using unfixed, unstained tissue. Aluminum Association. Aluminum and Health, 2 nd International Conference; Tampa, Florida. 1992.
  130. Smith, Q.; Deng, Q.; Brady, D.; Swyt, C.; Nguyen, J.; Gillen, G. Aluminum localization and analysis in stained and unstained human brain tissue using X-ray microanalysis and secondary ion mass spectrometry. Aluminum Association. Aluminum and Health, 3 rd International Conference; Miami, Florida. 1994.
  131. Søyseth V, Kongerud J, Kjuus H, Boe J. Bronchial responsiveness and decline in FEV in aluminum potroom workers. Eur Resp J 1994;7:888-894.
  132. Stevens BJ, Willis GL, Humphrey TJ, Atkins RC. Combined toxicity of aluminum and fluoride in the rat: possible implications in hemodialysis. Trace Elem Med 1987;4:61-66.
  133. Varo P, Koivistoinen P. Mineral element composition of Finnish foods: XII. General discussion and nutritional evaluation. Acta Agric Scand Suppl 1980;22:165-171.
  134. Wachi M, Aikawa K. Serum aluminum assay by flameless atomic absorption spectroscopic method and oral absorption of some aluminum compounds by rats. Oyo Yakuri 1975;10:359-363.
  135. Weinbrüch S, van Aken P, Ebert M, Thomassen Y, Skogstad A, Chashchin VP, Nikonov A. The heterogeneous composition of working place aerosols in a nickel refinery: a transmission and scanning electron microscope study. J Environ Monit 2002;4:344-350. [PubMed: 12094927]
  136. WHO (World Health Organization). Guidelines for Drinking-Water Quality. Vol. 3. Vol. 1. Geneva: World Health Organization; 2004. Recommendations
  137. Winterberg B, Bertram H, Korte R, Niederlain G, Remmers S, Remmers J, Zumkley H. Hair analysis for aluminum monitoring in patients on long-term hemodialysis. Trace Elem Med 1987b;4:72-74.
  138. World Bureau of Metal Statistics. World bauxite production. World Met Stat 1994;47:6.
  139. Wu Y, Zhou Z, Xiong Y, Wang Y, Sun J. Distribution of aluminum of alunite in blood and brain of normal mice and mice with high permeability of blood-brain barrier. Zhongguo Zhongyao Zazhi 1999;24:234-235.
  140. Yamamoto T, Watsuji T, Ishikawa M, Harina Y, Yabuki T. Zinc, copper, and aluminum contents of various human organs, especially of the male genital organs. Kobe Ika Daigaku Kiyo 1959;16:185- 190.
  141. Yase Y. The role of aluminum in CNS degeneration with interaction of calcium. Neurotoxicology 1980;1:101-109.
  142. Yasui MS, Kita SF, Yoshimasu F, Higashi Y, Yase Y, Uebayashi Y, Miyamoto K, Nagasaki Y, Miyoshi K, Hayashi S, Ogura Y. Accumulation of aluminum in central nervous system and other organs in a case of generalized amyloidosis. Nippon Naika Gakkai Zasshi 1980;69:982-991. [PubMed: 7205049]
  143. Yasui M, Yano I, Yase Y, Ota K. Aluminum contents in soft tissues of mice fed low Ca-Mg, low Ca-Mg + high aluminum, and low Ca-Mg+ high aluminum diets with administration of 1,25-(OH)2D3. Igaku no Ayumi 1990b;153:601-602.
  144. Yoshida H, Yoshimsu F, Chen KM. The study on trace elements in brains of dementia patients. Wakayama Igaku 1993;44:529-539.
  145. Yoshimasu F, Yasui M, Yoshida H, Yoshida S, Uebayashi Y, Yase Y, Gajdusek DC, Chen KM. Aluminum in Alzheimer's disease in Japan and parkinsonism-dementia in Guam. In 13th world congress of neurology. J Neurol 1985;232(Suppl):61. [PubMed: 4020395]
  146. Zumkley H, Spieker C, Kisters K, Zidek W, Fromme HG, Losse H, van Husen N, Bertram HP. Aluminum concentrations in gastric mucous membrane in renal insufficiency. Trace Subst Environ Health 1984a;18:40-46.
  147. Zumkley H, Schmidt PF, Bertram HP, Lison AE, Winterberg B, Spieker K, Losse H, Barckhaus R. Aluminum concentration of bone cells in dialysis osteomalacia. Trace Elem Med 1984b;1:103-106.
  148. Zumkley H, Bertram HP, Brandt M, Rodig M, Spieker C. Magnesium, aluminum and lead in various brain areas. Trace Subst Environ Health 1986;20:29-35.

Cited by

Sorted by citations

Authors
Krewski, D., Yokel, R. A., Nieboer, E., Borchelt, D., Cohen, J., Harry, J., Kacew, S., Lindsay, J., Mahfouz, A. M., & Rondeau, V.
Affiliations
  • University of Ottawa (CA)
  • University of Kentucky (US)
  • UiT The Arctic University of Norway (NO)
  • University of Florida (US)
  • Tufts Medical Center (US)
  • National Institutes of Health (US)
  • Public Health Agency of Canada (CA)
  • Environmental Protection Agency (US)
  • Inserm (FR)
Corresponding author
Krewski, Daniel
Venue
Journal of Toxicology and Environmental Health, Part B
Published
2007-11-16
Volume
10
Issue
sup1
Pages
1-269
ISSN
  • 1093-7404 (ISSN-L)
  • 1521-6950
OpenAlex
W2100043100
Cited by
998
References
1,426
Citations by year
2026: 29 · 2025: 54 · 2024: 61 · 2023: 89 · 2022: 71 · 2021: 98 · 2020: 109 · 2019: 92 · 2018: 79 · 2017: 58 · 2016: 57 · 2015: 42 · 2014: 44 · 2013: 30 · 2012: 27
FWCI
13.77
Type
journal article
Language
en
Open access
Locations
  • Journal of Toxicology and Environmental Health Part B (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • UKnowledge (University of Kentucky) (submittedVersion)
  • HAL (submittedVersion, other-oa)
Funders
National Institutes of Health (Z99-ES999999)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Aluminum toxicity and tolerance in plants and animals
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
Keywords
aluminum, alumina, aluminum hydroxide, human health risk assessment, aluminum toxicity
MeSH terms
Aluminum, Aluminum Hydroxide, Aluminum Oxide, Animals, Environmental Exposure, Humans, Tissue Distribution, Occupational Exposure, Aluminum Compounds, Risk Assessment, Toxicity Tests

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review